Pacira Biosciences Inc at JPMorgan Healthcare Conference Transcript
Hi, everybody. I'm Hardik Parikh at JPMorgan covering large-cap pharmaceuticals. I am pleased to have Frank Lee here, CEO of Pacira. He's going to start off with a presentation, and then we'll end up doing a little Q&A afterwards. Thank you.
Thank you, Hardik, for the invitation. Good morning, all here at JPMorgan and those of you following us online. So let me just kick this off with some forward-looking statements and start out with a quick overview of Pacira. Our mission is to deliver innovative non-opioid pain management therapies to transform lives. And we do that by following some simple guiding principles like keeping the patient at the center, following the science and treating our people well.
10-plus years of leadership in this space, last year, we reported actually early this year for last year, unaudited sales of $726 million, 800-plus employees that are highly engaged around our mission and to date, 18 million-plus
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
